<DOC>
	<DOCNO>NCT02404376</DOCNO>
	<brief_summary>Remote ischemic conditioning ( RIC ) intravenous exenatide administer immediately primary angioplasty find limit infarct size patient STEMI ( ST segment elevation myocardial infarction ) , reduction limit . This study investigate whether combination therapy include therapy effective .</brief_summary>
	<brief_title>COMBinAtion Therapy Myocardial Infarction : The COMBAT-MI Trial</brief_title>
	<detailed_description>COMBAT-MI investigator-driven , randomize , double-blind placebo-controlled clinical trial aim evaluate effect Remote Ischemic Conditioning exenatide , alone combination , Myocardial Infarct size 400 STEMI patient ( ST segment elevation myocardial infarction ) . Patients TIMI ( Thrombolysis Myocardial Infarction ) flow grade &gt; 1 exclude . The study 2 x 2 factorial design ( Remote Ischemic Conditioning , Exenatide , neither ) . The primary end-point Myocardial Infarct size measure Cardiac Magnetic Resonance Imaging ( CMRI ) perform 3 - 7 day primary Percutaneous Coronary Intervention ( pPCI ) ( express % leave ventricular ( LV ) mass ) . Secondary end-points include myocardial salvage index , base angiographic CMRI derive estimation area risk , frequency Major Adverse Cardiovascular Events ( MACE ) major adverse event admission .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Exenatide</mesh_term>
	<criteria>Men woman â‰¥18 year age STEMI characterize 2 mm ST segment elevation 2 V1 V4 lead presumed new leave bundle branch block minimum 1 mm concordant ST elevation 1 mV ( millivolt ) ST segment elevation limb lead ( II , III aVF lead , I , aVL lead ) V4V6 . Patients present within 6 hour chest pain . Known hypersensitivity exenatide excipients Known contraindication CMR image significant claustrophobia , severe allergy gadolinium chelate contrast , severe renal insufficiency ( define estimate glomerular filtration rate [ eGFR ] ( epidermal growth factor receptor ) &lt; 30 mL/min/1.73 m2 ) , presence CMRI contraindicate implanted device ( e.g. , pacemaker , implanted cardiac defibrillator , cardiac resynchronization therapy device , cochlear implant ) , embed metal object ( e.g. , shrapnel ) , contraindication CMRI . Assumed life expectancy &lt; 1 year e.g . due noncardiac disease . TIMI flow grade &gt; 1 time diagnostic coronary angiography . These patient exclude analysis infarct size include safety analysis . Pregnant woman Patients loss consciousness confuse , able read information sign writting consent Patients orotracheal intubation Patients cardiogenic shock persist 48h reperfusion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>STEMI</keyword>
	<keyword>Reperfusion Injury</keyword>
	<keyword>Myocardial Infarction</keyword>
	<keyword>Myocardial Ischemia</keyword>
	<keyword>Remote Ischemic Conditioning</keyword>
	<keyword>Exenatide</keyword>
	<keyword>Glucagon-Like Peptide-1 ( GLP-1 )</keyword>
	<keyword>Acute Coronary Syndrome</keyword>
	<keyword>Cardioprotection</keyword>
</DOC>